Clinical Outcomes of Tirzepatide After Metabolic Bariatric Surgery: A Systematic Review
Diabetes, Metabolic Syndrome and Obesity · 2026-11 · Volume 19 · 1-13
DOI: 10.2147/dmso.s656297 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Diabetes, Metabolic Syndrome and Obesity, 2026-11. Verfasst von Ghadeer L Alfuhaydi und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy Practice, College of Pharmacy, Qassim University, Qassim, Saudi Arabia. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacy Practice, College of Pharmacy, Qassim University, Qassim, Saudi Arabia.
ORCID-Profile: Osamah M Alfayez
Zitieren
APA
Alfuhaydi, G. L., Alahmed, A. A., & Alfayez, O. M. (2026). Clinical Outcomes of Tirzepatide After Metabolic Bariatric Surgery: A Systematic Review. Diabetes, Metabolic Syndrome and Obesity, Volume 19, 1-13. https://doi.org/10.2147/dmso.s656297
Vancouver
Alfuhaydi GL, Alahmed AA, Alfayez OM. Clinical Outcomes of Tirzepatide After Metabolic Bariatric Surgery: A Systematic Review. Diabetes, Metabolic Syndrome and Obesity. 2026;Volume 19:1-13. doi:10.2147/dmso.s656297
BibTeX
@article{Alfuhaydi2026,
author = {Alfuhaydi, Ghadeer L and Alahmed, Abdullah A and Alfayez, Osamah M},
title = {Clinical Outcomes of Tirzepatide After Metabolic Bariatric Surgery: A Systematic Review},
journal = {Diabetes, Metabolic Syndrome and Obesity},
year = {2026},
volume = {Volume 19},
pages = {1--13},
doi = {10.2147/dmso.s656297}
}
EUVIMED